Insilico Medicine

Insilico Medicine
TypePublic
SEHK: 3696
IndustryBiotechnology
Founded2014 (2014)
FounderAlex Zhavoronkov
Headquarters1000 Massachusetts Avenue,
Number of locations
6
Area served
Artificial intelligence, deep learning
Key peopleAlex Zhavoronkov, PhD, Feng Ren, PhD, Alex Aliper
ServicesDrug discovery
Websiteinsilico.com

Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company applies genomics, big data analysis, and deep learning for in silico drug discovery.